| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/14/2001 | WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001017989A3 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 06/14/2001 | WO2001016133A3 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | WO2000064441A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 06/14/2001 | US20010003749 Arylpiperazines having activity at the serotonin 1A receptor |
| 06/14/2001 | US20010003747 Useful in treating or in preventing melatoninergic disorders |
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2394928A1 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393470A1 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2390676A1 Method of testing remedy or preventive for hyperlipemia |
| 06/14/2001 | CA2384982A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2361647A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/14/2001 | CA2361563A1 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic or xenogenic cells |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106608A1 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/13/2001 | EP1106599A1 Chromium l-threonate, process for preparation of the same and their use |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1106184A2 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/13/2001 | EP1106180A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105481A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 06/13/2001 | EP1105460A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105378A1 Quinazoline derivatives |
| 06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
| 06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105138A1 Chromium polynicotinate compositions and uses thereof |
| 06/13/2001 | EP1105123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 06/13/2001 | EP1105122A1 Pharmaceutical compositions containing lipase inhibitors |
| 06/13/2001 | EP1105121A1 Ascorbate-isoquercetin compositions |
| 06/13/2001 | EP0666858B1 5-arylindole derivatives and their use as serotonin (5-ht 1) agonists |
| 06/13/2001 | EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/13/2001 | DE19956400A1 Cholesterol-lowering cardioprotective and vasoprotective composition comprises conjugated linoleic acids and omega-3 fatty acids |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299283A Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
| 06/13/2001 | CN1299234A Method and compounds for the genetic treatment of hyperlipidemia |
| 06/13/2001 | CN1298730A Process for preparing 'Qianjin' capsule to treat genopathy |
| 06/13/2001 | CN1298729A Medical tea for curing diabetes |
| 06/13/2001 | CN1298701A Compound amino acid composition |
| 06/13/2001 | CN1298698A Health-care oil for regulating blood fat |
| 06/13/2001 | CN1298647A Health-care oil for regulating blood fat |
| 06/13/2001 | CN1067076C Method for prepn. of substituted thiacycloalkeno [3,2-6] pyridines pharmaceutical compositions |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1066939C Pharmaceutical composition contg. thiazolidine denvative and prepn. process-thereof |
| 06/13/2001 | CN1066930C Cholesterol lowering drink mixture compositions |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245803 Palatable elemental medical food |
| 06/12/2001 | US6245778 1,6-naphthyridine anti-convulsants |
| 06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245744 Antilipemic agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245365 Arachidonic acid |
| 06/12/2001 | US6245326 Health supplement |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/12/2001 | CA2077762C New use of bambuterol |
| 06/12/2001 | CA2014544C Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040348A2 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
| 06/07/2001 | WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040192A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | WO2001040190A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor |
| 06/07/2001 | WO2001040182A2 Solid pharmaceutical preparation |
| 06/07/2001 | WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
| 06/07/2001 | WO2001040172A1 New tri-substituted phenyl derivatives and analogues |
| 06/07/2001 | WO2001040171A1 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | WO2001040170A1 New phenalkyloxy-phenyl derivatives |
| 06/07/2001 | WO2001040169A1 Comminuted form of (s)-2-ethoxy -3-[4-(2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |